MAK — MATERNUS-Kliniken-AG Cashflow Statement
0.000.00%
- €33.76m
- €210.68m
- €102.31m
- 59
- 87
- 23
- 58
Annual cashflow statement for MATERNUS-Kliniken-AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -12.6 | -7.78 | -1.96 | -12.8 | -12.6 |
Depreciation | |||||
Non-Cash Items | -1.31 | 6.71 | 6.76 | 4.35 | 7.08 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 18.3 | 1.64 | 1.33 | 1.79 | -1.72 |
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 16 | 12.2 | 17.2 | 4.33 | 2.52 |
Capital Expenditures | -0.961 | -0.736 | -1.93 | -2 | -3.96 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.186 | 0.034 | 0.008 | 0.002 | 0 |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.775 | -0.702 | -1.92 | -2 | -3.96 |
Financing Cash Flow Items | -7.94 | -7.05 | -5.99 | -5.77 | -7.53 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -16.4 | -2.23 | -12.8 | -12.8 | -0.069 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.17 | 9.24 | 2.54 | -10.4 | -1.51 |